Tolvaptan (JYNARQUE) 45MG/15MG NDC: 59148-0087-28
Ended Awarded
- Contract number
- 36C26124N0563
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. has been awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 for the supply of Tolvaptan (Jynarque) 45mg/15mg tablets, with a contract ceiling value of $12,580.72. This firm fixed-price delivery order, issued on April 8, 2024, with an ultimate completion date of May 8, 2024, represents a task order against Otsuka America's larger Indefinite Delivery Vehicle with the VA. The contract does not utilize a set-aside designation and is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The medication will be delivered to Potomac, Maryland.
Jynarque (tolvaptan) is a specialized pharmaceutical treatment for autosomal dominant polycystic kidney disease and hyponatremia, representing a critical therapeutic option within the VA's comprehensive healthcare services for veterans. This delivery order is one of multiple task orders issued to Otsuka America across various VA Integrated Service Networks, supported by the company's substantial $83.3 million Blanket Purchase Agreement for Jynarque through the National Acquisition Center, which extends through March 26, 2026. The procurement streamlines the VA's ability to provide specialized pharmaceutical treatments to veterans nationwide through an established contractor relationship with proven capability in federal healthcare supply.
Quick answers
Who was awarded contract 36C26124N0563?
36C26124N0563 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 8, 2024.
How much is contract 36C26124N0563 worth?
The government has obligated $12,581 on 36C26124N0563.
Is contract 36C26124N0563 an order under another contract?
Yes. 36C26124N0563 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0563 competed?
The extent of competition for 36C26124N0563 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award